Limor Zur-Stoller
Nessuna posizione attualmente
Profilo
Limor Zur-Stoller served as Vice President-Finance & Investor Relations at RadView Software Ltd.
She was also Chief Financial Officer & Treasurer at Gammacan International, Inc. from 2008 to 2011.
From 2008 to 2010, she held the position of Vice President-Finance at Rosetta Genomics Ltd.
Later, she served as Chief Financial Officer & IR Contact at G.F.C Green Fields Capital Ltd.
from 2012 to 2015.
Zur-Stoller completed her undergraduate degree from Tel-Aviv University.
Precedenti posizioni note di Limor Zur-Stoller
| Società | Posizione | Fine |
|---|---|---|
| ROSETTA GENOMICS LTD. | Direttore Finanziario/CFO | 01/10/2010 |
| G.F.C GREEN FIELDS CAPITAL LTD. | Direttore Finanziario/CFO | - |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Direttore Finanziario/CFO | - |
| RADVIEW SOFTWARE LTD. | Direttore Finanziario/CFO | - |
Formazione di Limor Zur-Stoller
| Tel-Aviv University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| RADVIEW SOFTWARE LTD. | Technology Services |
| ROSETTA GENOMICS LTD. | Health Technology |
| G.F.C GREEN FIELDS CAPITAL LTD. | Finance |
| Aziende private | 1 |
|---|---|
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
- Borsa valori
- Insiders
- Limor Zur-Stoller
